Abelson Helper Integration Site-1 Gene Variants on Major Depressive Disorder and Bipolar Disorder
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective The present study aimed to explore whether 4 single nucleotide polymorphisms (SNPs) within the AHI1 gene could be associated with major depressive disorder (MD) and bipolar disorder (BD), and whether they could predict clinical outcomes in mood disorders. Methods One hundred and eighty-four (184) patients with MD, 170 patients with BD and 170 healthy controls were genotyped for 4 AHI1 SNPs (rs11154801, rs7750586, rs9647635 and rs9321501). Baseline and final clinical measures for MD patients were assessed through the Hamilton Rating Scale for Depression (HAM-D). Allelic and genotypic frequencies in MD and BD subjects were compared with those of each disorder and healthy group using the χ2 statistics. Repeated measures ANOVA was used to test possible influences of SNPs on treatment efficacy. Results The rs9647635 A/A was more represented in subjects with BD as compared with MD and healthy subjects together. The rs9647635 A/A was also more presented in patients with MD than in healthy subjects. With regard to the allelic analysis, rs9647635 A allele was more represented in subjects with BD compared with healthy subjects, while it was not observed between patients with MD and healthy subjects. Conclusion Our findings provide potential evidence of an association between some variants of AHI1 and mood disorders susceptibility but not with clinical outcomes. However, we will need to do more adequately-powered and advanced association studies to draw any conclusion due to clear limitations.
Abstract
Objective The present study aimed to explore whether 4 single nucleotide polymorphisms (SNPs) within the AHI1 gene could be associated with major depressive disorder (MD) and bipolar disorder (BD), and whether they could predict clinical outcomes in mood disorders. Methods One hundred and eighty-four (184) patients with MD, 170 patients with BD and 170 healthy controls were genotyped for 4 AHI1 SNPs (rs11154801, rs7750586, rs9647635 and rs9321501). Baseline and final clinical measures for MD patients were assessed through the Hamilton Rating Scale for Depression (HAM-D). Allelic and genotypic frequencies in MD and BD subjects were compared with those of each disorder and healthy group using the χ2 statistics. Repeated measures ANOVA was used to test possible influences of SNPs on treatment efficacy. Results The rs9647635 A/A was more represented in subjects with BD as compared with MD and healthy subjects together. The rs9647635 A/A was also more presented in patients with MD than in healthy subjects. With regard to the allelic analysis, rs9647635 A allele was more represented in subjects with BD compared with healthy subjects, while it was not observed between patients with MD and healthy subjects. Conclusion Our findings provide potential evidence of an association between some variants of AHI1 and mood disorders susceptibility but not with clinical outcomes. However, we will need to do more adequately-powered and advanced association studies to draw any conclusion due to clear limitations.
참고문헌 (29)
- Alda M, "Genetic factors and treatment of mood disorders", Bipolar Disord, 3, pp.318~324 (2001)
- Pae CU, "Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia", Neuropsychobiology, 65, pp.1~11 (2012)
- Kendler KS, "A Swedish national twin study of lifetime major depression", Am J Psychiatry, 163, pp.109~114 (2006)
- Smoller JW, "Family, twin, and adoption studies of bipolar disorder", Am J Med Genet C Semin Med Genet, 123C, pp.48~58 (2003)
- Zubenko GS, "Genome-wide linkage survey for genetic loci that affect the risk of suicide attempts in families with recurrent, early-onset, major depression", Am J Med Genet B Neuropsychiatr Genet, 129B, pp.47~54 (2004)
- Sheng G, "Huntingtin-associated protein 1 interacts with Ahi1 to regulate cerebellar and brainstem development in mice", J Clin Invest, 118, pp.2785~2795 (2008)
- Wang AY, "Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region", Acta Neuropathol, 122, pp.615~626 (2011)
- Lisman JE, "Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia", Trends Neurosci, 31, pp.234~242 (2008)
- Doering JE, "Species differences in the expression of Ahi1, a protein implicated in the neurodevelopmental disorder Joubert syndrome, with preferential accumulation to stigmoid bodies", J Comp Neurol, 511, pp.238~256 (2008)
- David DJ, "Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety", depression, 2009, pp.62, 479~493
- Xu X, "Neuronal Abelson helper integration site-1 (Ahi1) deficiency in mice alters TrkB signaling with a depressive phenotype", Proc Natl Acad Sci U S A, 107, pp.19126~19131 (2010)
- Martinowich K, "New insights into BDNF function in depression and anxiety", Nat Neurosci, 10, pp.1089~1093 (2007)
- Angelucci F, "BDNF in schizophrenia, depression and corresponding animal models", Mol Psychiatry, 10, pp.345~352 (2005)
- Sperlagh B, "The role of purinergic signaling in depressive disorders", Neuropsychopharmacol Hung, 14, pp.231~238 (2012)
- Chiu CT, "Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder", Pharmacol Rev, 65, pp.105~142 (2013)
- Lotan A, "Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders", Mol Psychiatry, 19, pp.243~252 (2014)
- Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
- Montgomery SA, "A new depression scale designed to be sensitive to change", Br J Psychiatry, 134, pp.382~389 (1979)
- Barrett JC, "Haploview: analysis and visualization of LD and haplotype maps", Bioinformatics, 21, pp.263~265 (2005)
- Benjamini Y, "Controlling the false discovery rate in behavior genetics research", Behav Brain Res, 125, pp.279~284 (2001)
- Amann-Zalcenstein D, "AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia", Eur J Hum Genet, 14, pp.1111~1119 (2006)
- Alvarez Retuerto AI, "Association of common variants in the Joubert syndrome gene (AHI1) with autism", Hum Mol Genet, 17, pp.3887~3896 (2008)
- Ingason A, "A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia", Hum Mol Genet, 19, pp.1379~1386 (2010)
- Ingason A, "Support for involvement of the AHI1 locus in schizophrenia", Eur J Hum Genet, 15, pp.988~991 (2007)
- Slonimsky A, "Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder", Schizophr Res, 120, pp.159~166 (2010)
- Sullivan PF, "Spurious genetic associations", Biol Psychiatry, 61, pp.1121~1126 (2007)
- Lichtenstein P, "Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study", Lancet, 373, pp.234~239 (2009)
- Cavalli-Sforza L, "The History and Geography of Human Genes" (1994), Princeton University Press
- Alberto Chiesa, "Epistatic Interactions between CREB and CREM Variants in Affective Disorder", PSYCHIATRY INVESTIGATION, 11(2), pp.200~203 (2014), 대한신경정신의학회[DOI]